Fact CheckerSign in

NCT06968871Recruiting

Ameliorated Pap Tests and Cervical Cancer Screening Participation

Effects of the Ameliorated Pap Test on Cervical Cancer Screening Participation: a Multicenter Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 30 Oct 2026

Brief summary (registry, in English)

The Pap test plays a crucial role in the early detection of cervical cancer. A pilot single-center randomized controlled trial applied the peak-end concept and added a non-painful step at the end of Pap smear screening, aimed to reduce recalled pain. However, there is still no multicenter study investigating the effect of the modified Pap test on cervical cancer screening participation. The present project is the first multicenter randomized controlled trial to expand the current scope of the peak-end theory into Pap tests and cervical cancer screening participation by adding a non-painful step at the end of Pap smear screening. Our multidisciplinary team (NTUH Pap Study Group) aims to provide innovative, feasible, and low-cost strategies for cervical cancer screening participation.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
850 (estimated)
First submitted
27 Apr 2025
Start date
1 Mar 2026
Primary completion date
31 Dec 2030
Lead sponsor
National Taiwan University Hospital
NCT number
NCT06968871

What you commit to

  • Study type: Interventional
  • Planned participants: 850
  • From 1 Mar 2026 to the primary completion date, 31 Dec 2030
  • 5 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Any active cancer at study entry (defined as cancer diagnosed or treated within the previous 6 months, recurrent, regionally advanced or metastatic cancer)
  • Previous hysterectomy, pelvic surgery, or radiotherapy

Other illness

  • Active vaginal or uterus infection

Other

  • Ongoing menstruation
  • Pregnancy
  • Incapability of understanding the numeric pain scales
  • Analgesic use within 24 hours

Who the study is looking for

  • Women aged 25 or above

Age in the registry: 25 years to - · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (5)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
National Taiwan University Hospital Yunlin Branch
Coordinator of this site? Confirm its status
DouliuTaiwanRecruiting
National Taiwan University Hospital Hsin Chu Branch
Coordinator of this site? Confirm its status
HsinchuTaiwanRecruiting
National Taiwan University Hospital Beihu Branch
Coordinator of this site? Confirm its status
TaipeiTaiwanRecruiting
National Taiwan University Hospital
Coordinator of this site? Confirm its status
TaipeiTaiwanRecruiting
National Taiwan University Cancer Center
Coordinator of this site? Confirm its status
TaipeiTaiwanRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.